Huntington's Disease-Update on Treatments

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Huntington's disease (HD) is an inherited neurodegenerative disorder with progressive motor, behavioral, and cognitive decline.
• Current treatments for HD focus on managing symptoms like chorea and psychiatric issues, with limited success for many other symptoms.
• Despite understanding the genetic cause for over 20 years, effective disease-modifying therapies for HD are lacking.

Purpose of the Study:

• To review the current state of Huntington's disease treatment.
• To explore the potential of emerging gene silencing techniques as a disease-modifying therapy for HD.
• To highlight the limitations of existing symptomatic treatments for Huntington's disease.

Main Methods:

• Literature review of current Huntington's disease treatments.
• Analysis of molecular models and their therapeutic implications.
• Evaluation of gene silencing techniques for neurodegenerative diseases.

Main Results:

• Symptomatic treatments, such as those reducing dopaminergic neurotransmission, offer partial relief for specific HD symptoms like chorea.
• High-quality evidence supporting general HD treatments remains limited.
• Minimal success has been achieved in developing disease-modifying therapies based on molecular models.

Conclusions:

• Existing treatments for Huntington's disease primarily manage symptoms, with significant unmet needs.
• Gene silencing techniques represent a promising avenue for developing a disease-modifying therapy for Huntington's disease.
• Further research into gene silencing is crucial for a breakthrough in treating this devastating condition.